Ligand · BMI
BMI · 3-[5-(1H-imidazol-1-yl)-7-methyl-1H-benzimidazol-2-yl]-4-[(pyridin-2-ylmethyl)amino]pyridin-2(1H)-one
BMI, 3-[5-(1H-imidazol-1-yl)-7-methyl-1H-benzimidazol-2-yl]-4-[(pyridin-2-ylmethyl)amino]pyridin-2(1H)-one (C22 H19 N7 O, 397.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- BMI
- Formula
- C22 H19 N7 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
BMI in 2 structures; the first of them:
- 2OJ9 · Structure of IGF-1R kinase domain complexed with a benzimidazole inhibitor · BMI A301 · binds LEU975, GLY976, GLN977, GLY978, VAL983, ALA1001, LYS1003, VAL1033 and 11 more
- 2OJ9 · Structure of igf-1R kinase domain complexed with a benzimidazole inhibitor · BMI A301 · binds LEU975, GLY976, GLN977, GLY978, VAL983, ALA1001, LYS1003, VAL1033 and 11 more
Residues it binds most
MET 2, GLY 2, LEU 2, THR 2, VAL 2, ALA 2, ARG 2, ASP 2, GLN 2, GLU 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.